Quantcast
The Mesh Report - Growth Stock Network

Growth Stock Network »

5 Reasons Canopy Growth Doesn’t Deserve a Lofty Premium

5 Reasons Canopy Growth Doesn’t Deserve a Lofty Premium

Growth Stock Network July 29, 2019 Comments Off on 5 Reasons Canopy Growth Doesn’t Deserve a Lofty Premium

For years, the marijuana industry has been all the buzz on Wall Street. That’s because legal weed could become an industry that generates $100 billion, or perhaps even $200 billion, in annual worldwide sales

Read More »
Do Marijuana Stocks Have a Trust Problem?

Do Marijuana Stocks Have a Trust Problem?

Growth Stock Network July 26, 2019 Comments Off on Do Marijuana Stocks Have a Trust Problem?

For years, the marijuana industry has been thriving, and the expectation is that even greener pastures await. After all, according to a recently released report from Arcview Market Research and BDS Analytics, “The State

Read More »
Cannabis News: Cash Is King

Cannabis News: Cash Is King

Growth Stock Network July 25, 2019 Comments Off on Cannabis News: Cash Is King

Many cannabis companies are finding it difficult to raise capital, and it can be challenging for marijuana producers to obtain financing at attractive rates. This is particularly true for smaller growers. Analysts at Stifel Financial recently

Read More »
Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?

Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?

Growth Stock Network July 24, 2019 Comments Off on Will Aurora, Canopy, Cronos, and Tilray Be Profitable by 2021?

Over the next decade, you’d struggle to find an industry that offers the growth potential of legal cannabis. Unlike new technologies, cannabis has been around for a long time and is a proven industry

Read More »
2 Penny Stock Marijuana Plays That Could Make You Rich

2 Penny Stock Marijuana Plays That Could Make You Rich

Growth Stock Network July 23, 2019 Comments Off on 2 Penny Stock Marijuana Plays That Could Make You Rich

Penny stocks — those trading under $5 per share — are risky by their very nature. And that statement is arguably doubly true for cannabis stocks. Numerous pot companies, after all, have run afoul

Read More »
Where Will Tilray Be in 5 Years?

Where Will Tilray Be in 5 Years?

Growth Stock Network July 22, 2019 Comments Off on Where Will Tilray Be in 5 Years?

Pot stocks are only now coming into their own as legitimate investing vehicles. Underscoring this point, the first G8 country to legalize adult-use marijuana, Canada, did so less than a full year ago, major

Read More »
3 Top Healthcare Stocks to Buy Right Now

3 Top Healthcare Stocks to Buy Right Now

Growth Stock Network July 19, 2019 Comments Off on 3 Top Healthcare Stocks to Buy Right Now

Healthcare stocks haven’t quite outperformed the broader markets this year, per usual, but they have performed admirably given all of the political headwinds facing the sector as a whole. The sector’s resilience during this

Read More »
Curaleaf Makes a Pot Deal

Curaleaf Makes a Pot Deal

Growth Stock Network July 18, 2019 Comments Off on Curaleaf Makes a Pot Deal

The stock market was once again fairly quiet on Wednesday, as the beginning of earnings season brought some mixed views about the state of the overall U.S. economy. Investors remain uncertain how policymakers will

Read More »
The 3 Most Profitable Marijuana Stocks You Can Buy Right Now

The 3 Most Profitable Marijuana Stocks You Can Buy Right Now

Growth Stock Network July 17, 2019 Comments Off on The 3 Most Profitable Marijuana Stocks You Can Buy Right Now

In 2019, the vast majority of licensed cannabis producers have been losing money at a time when investors were expecting the profits to start rolling in. Among those with at least $20 million in

Read More »
Say Hello to This Unique (and New) Cannabis ETF

Say Hello to This Unique (and New) Cannabis ETF

Growth Stock Network July 16, 2019 Comments Off on Say Hello to This Unique (and New) Cannabis ETF

There’s no denying that there’s a lot of buzz surrounding the cannabis space — and for good reason.  First, Wall Street has tossed around some very prolific long-term sales growth figures for the global

Read More »